The journal of sexual medicine · 2014
Sexual dysfunction in men seeking treatment for opioid dependence: a study from India.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Venkatesh Kandappan, Mattoo Surendra K, Grover Sandeep
Аннотация
INTRODUCTION: There is limited literature on opioid dependence patients for the prevalence of sexual dysfunction as assessed by validated questionnaires.
AIM: To study the prevalence and specified demographic and clinical correlates of sexual dysfunction in men seeking treatment for opioid dependence by using multiple validated instruments.
METHODS: Men with opioid dependence for at least 1 year as per DSM-IV (confirmed by Mini International Neuropsychiatric Interview) (OD group, N=100) and matched healthy controls (HC group, N=50) were evaluated for sexual dysfunction.
MAIN OUTCOME MEASURES: Arizona Sexual Experience Questionnaire (ASEX), International Index of Erectile Function (IIEF) and Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14).
RESULTS: In men seeking treatment for opioid dependence sexual dysfunction was recorded in 48% by ASEX, and in at least one of the domains in 92% by IIEF and in 90% by CSFQ; in comparison with the healthy controls, the prevalence of sexual dysfunction in patients with opioid dependence was significantly higher by each measure.
CONCLUSIONS: Compared with healthy controls, sexual dysfunction rates are higher in patients seeking treatment for opioid dependence.
AIM: To study the prevalence and specified demographic and clinical correlates of sexual dysfunction in men seeking treatment for opioid dependence by using multiple validated instruments.
METHODS: Men with opioid dependence for at least 1 year as per DSM-IV (confirmed by Mini International Neuropsychiatric Interview) (OD group, N=100) and matched healthy controls (HC group, N=50) were evaluated for sexual dysfunction.
MAIN OUTCOME MEASURES: Arizona Sexual Experience Questionnaire (ASEX), International Index of Erectile Function (IIEF) and Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14).
RESULTS: In men seeking treatment for opioid dependence sexual dysfunction was recorded in 48% by ASEX, and in at least one of the domains in 92% by IIEF and in 90% by CSFQ; in comparison with the healthy controls, the prevalence of sexual dysfunction in patients with opioid dependence was significantly higher by each measure.
CONCLUSIONS: Compared with healthy controls, sexual dysfunction rates are higher in patients seeking treatment for opioid dependence.